HOLOGIC ($NASDAQ:HOLX) reported revenues of USD 945.3 million and net income of USD 90.6 million for the fourth quarter of FY2023, representing a 0.8% and 23.7% year-on-year decrease respectively, when compared to the same period in 2023.
On Thursday, HOLOGIC reported record earnings of USD 945.3 million for the fourth quarter of FY2023, a 23.7% increase from the same quarter the previous year. The news of HOLOGIC’s positive performance in Q4 FY2023 caused their stock to open at $68.3 on Thursday but close at $67.2 after the end of the day, a 1.6% decrease from its previous closing price. Despite this slight dip, analysts remain upbeat about the company’s performance and expect it to continue to post strong results over the next few quarters. Live Quote…
About the Company
Ownership (Institutional/ Fund Holdings)
Below shows the total revenue, net income and net margin for Hologic. More…
Income Statement Reports (Yearly/ Quarterly/ LTM)
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Hologic. More…
Cash Flow Statement (Yearly/ Quarterly/ LTM)
Cash Flow Supplement
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Hologic. More…
Balance Sheet (Yearly/ Quarterly)
Balance Sheet Supplement
||Book Value Per Share
Key Ratios Snapshot
Some of the financial key ratios for Hologic are shown below. More…
Income Statement Ratios
Balance Sheet Ratios
Cash Flow Ratios
Other Supplementary Items
|3Y Rev Growth
||3Y Operating Profit Growth
Analysis – Hologic Stock Fair Value
At GoodWhale, we recently conducted an analysis of HOLOGIC‘s financials. Our proprietary Valuation Line revealed that the intrinsic value of HOLOGIC share is around $63.8. This implies that investors might not be able to gain any significant returns from buying HOLOGIC stock at this current price. More…
Star Chart Analysis
The company’s products are used in a variety of settings, including hospitals, clinics, and physician offices. Hologic also provides a range of services, including support, training, and education. The company has a strong presence in the United States and international markets, and its products are backed by a large body of scientific research. ALR Technologies Inc, G Medical Innovations Holdings Ltd, and Omega Diagnostics Group PLC are all competitors of Hologic Inc.
– ALR Technologies Inc ($OTCPK:ALRT)
ALR Technologies Inc is a publicly traded company with a market capitalization of $19.32 million as of 2022. The company has a return on equity of 17.26%. ALR Technologies is a leading provider of enterprise software solutions. The company’s products are used by organizations of all sizes to manage their businesses. ALR Technologies’ products are used by companies in a variety of industries, including healthcare, manufacturing, retail, and government.
– G Medical Innovations Holdings Ltd ($NASDAQ:GMVD)
As of 2022, Aetna’s market cap was 5.58M and its ROE was 783.79%. Aetna is a diversified healthcare benefits company that offers a broad range of traditional and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, and medical management capabilities and health care management services for Medicaid plans.
– Omega Diagnostics Group PLC ($LSE:ODX)
Omega Diagnostics Group PLC is a medical diagnostics company. The company develops, manufactures, and supplies diagnostic test kits and instruments. It offers tests for the detection of allergies, food intolerances, infectious diseases, and hormones. The company sells its products through a network of distributors in the United Kingdom, Europe, the United States, Asia, Australia, and Africa.
HOLOGIC‘s fourth quarter FY2023 results showed a decrease in total revenue of 0.8% and net income of 23.7%, relative to the same period of the previous year. Despite the decline, analysts have pointed to the company’s strong balance sheet and low debt-to-equity ratio as reasons to remain bullish on the stock. Investors will be watching for improvements in gross margins, as well as a reduction in operating expenses as HOLOGIC works to reduce its reliance on volatile markets and return to healthy growth. With the company’s long-term prospects looking promising, investors may find HOLOGIC to be an attractive option in the current market environment.